创新药
Search documents
从“猎人”到“农夫” 躬身培育硬科技新苗
Zhong Guo Zheng Quan Bao· 2025-10-19 22:20
"当中国科技成为全球资本瞩目的焦点,其背后既有中国科技创新十年磨一剑的积淀,也得益于创投机 构从'猎人'到'农夫'的角色蜕变。"普华资本董事长曹国熊在接受中国证券报记者采访时表示。 曹国熊表示,从坚持科技赛道的长期主义,到孵化模式的创新突破,创投机构的价值不仅在于发现未 来,更在于参与创造未来。在让"创新浙江"成为中国式现代化省域先行的鲜明标识,以及全球资本纷纷 聚焦中国科技的背景下,创投机构的新探索正为行业提供新的破局思路。普华资本持续看好人工智能 (AI)、创新药、商业航天等赛道的投资机遇。 科技赛道爆火有其深层逻辑 "科技赛道的热度,不是突然出现的。"提及杭州"六小龙"引发的关注,曹国熊表示,这背后离不开创投 机构十年磨一剑的前瞻布局。 他举例说,普华资本早在2015年就组建了三支聚焦硬科技的团队,2016年切入生物医药领域,2018年布 局商业航天赛道等,这些看似超前之举,实则是基于对国家科技创新趋势的精准把握。 在曹国熊看来,杭州拥有"热带雨林"式的创新生态,明星项目的涌现既得益于这种氛围,也离不开资本 市场支持新质生产力的系列举措以及港股市场的持续活跃。 "耐心资本"同样是支撑科技企业长周期发展的 ...
从“猎人”到“农夫”躬身培育硬科技新苗
Zhong Guo Zheng Quan Bao· 2025-10-19 20:13
● 本报记者 昝秀丽 "当中国科技成为全球资本瞩目的焦点,其背后既有中国科技创新十年磨一剑的积淀,也得益于创投机 构从'猎人'到'农夫'的角色蜕变。"普华资本董事长曹国熊在接受中国证券报记者采访时表示。 曹国熊表示,从坚持科技赛道的长期主义,到孵化模式的创新突破,创投机构的价值不仅在于发现未 来,更在于参与创造未来。在让"创新浙江"成为中国式现代化省域先行的鲜明标识,以及全球资本纷纷 聚焦中国科技的背景下,创投机构的新探索正为行业提供新的破局思路。普华资本持续看好人工智能 (AI)、创新药、商业航天等赛道的投资机遇。 科技赛道爆火有其深层逻辑 "科技赛道的热度,不是突然出现的。"提及杭州"六小龙"引发的关注,曹国熊表示,这背后离不开创投 机构十年磨一剑的前瞻布局。 他举例说,普华资本早在2015年就组建了三支聚焦硬科技的团队,2016年切入生物医药领域,2018年布 局商业航天赛道等,这些看似超前之举,实则是基于对国家科技创新趋势的精准把握。 管理规模超过300亿元;累计投资600多个项目,其中三分之一已完成退出;投资字节跳动、中际旭创、 三六零、中控技术、毛戈平等80家赛道龙头……这是普华资本投资20多年来 ...
策略周报20251019:调整空间有限,保持信心-20251019
Orient Securities· 2025-10-19 14:14
Group 1 - The report concludes that the adjustment space for the index is limited, maintaining a judgment of sideways fluctuations and continued strength. The recent market pullback is attributed to strong short-term profit-taking motivation and a cautious stance amid uncertainties between China and the US. However, the report believes that the factors driving profit-taking are temporary, and the attractiveness of the equity market and long-term investor confidence remain unchanged. It is anticipated that the situation between China and the US will stabilize, with limited adverse effects on the market [3][12]. Group 2 - The report emphasizes continued high attention to technology as the main theme for investment opportunities. It suggests focusing on low-positioned self-controlled sectors (such as software), technology related to the 14th Five-Year Plan (including quantum technology, deep-sea economy, and brain-computer interfaces), and innovative pharmaceuticals. The report advises avoiding equipment-related sectors and previously high-performing technology companies, which have seen significant pullbacks recently. This ongoing correction is expected to enhance the attractiveness of core companies within these sectors, gradually attracting funds for reallocation [4][13]. Group 3 - In non-technology sectors, the report expresses a positive outlook on strategic metals, ranking them as follows: gold > rare earths and other minor metals > copper. For gold, the dual benefits of deteriorating fiat currency credit and safe-haven demand are expected to continue driving prices, despite short-term pullback risks. The strategic value of rare earths is anticipated to rise due to upgraded export controls on items and technologies. In the case of copper, demand is expected to increase in the medium term due to global grid upgrades, data center expansions, and the proliferation of electric vehicles, while ongoing disruptions in upstream mining will significantly exacerbate supply shortages, leading to a potential rise in copper prices [5][14].
长假后5个交易日近900亿元资金借道ETF入市
Shang Hai Zheng Quan Bao· 2025-10-19 12:31
Group 1 - The core viewpoint of the article highlights a significant inflow of nearly 90 billion yuan into the market through ETFs in the five trading days following the holiday, indicating strong investor interest despite market adjustments [1] - The total net inflow of ETFs from October 9 to October 15 reached 87.87 billion yuan, with stock ETFs and cross-border ETFs being the primary contributors [1][2] - The stock ETFs showed a bifurcated trend, with a net inflow of 68.95 billion yuan while bond ETFs experienced a net outflow of 17.79 billion yuan during the same period [1][2] Group 2 - Within stock ETFs, there is a preference for technology growth and dividend defensive strategies, characterized as a "dumbbell" approach, with the top performer being the Jiashi Shanghai Stock Exchange Science and Technology Innovation Board Chip ETF, which saw a net inflow of 4.06 billion yuan [2] - In the cross-border ETF segment, funds are primarily flowing into the Hong Kong stock market, particularly in technology and internet sectors, with the Hang Seng Technology Theme ETF capturing six of the top ten inflows [2] - Leveraged funds are also accelerating their entry into the stock ETF market, with net purchases exceeding 100 billion yuan in the five trading days following October 9 [2] Group 3 - Looking ahead, the market outlook suggests that dividend assets and gold may provide protection during periods of declining risk appetite, while AI is expected to present active opportunities in the medium to long term [3] - The A-share market is likely to remain in an upward cycle, driven by multiple factors including performance, liquidity, and policy support, with a continued emphasis on technology innovation [3]
“避风港”行情来袭!公募人士:港股或更有分红优势
Zheng Quan Shi Bao Wang· 2025-10-19 09:35
Core Viewpoint - The market is shifting towards dividend stocks as a defensive strategy, particularly in the context of recent volatility in growth sectors like technology and solid-state batteries [1][2][3] Group 1: Market Trends - The technology sector and solid-state battery stocks have cooled off, leading to a renewed focus on dividend assets as a safe haven for investors [1] - As of October 17, the Shanghai and Shenzhen indices have seen declines of over 1% and 6% respectively, while the CSI Dividend Index has increased by approximately 2.48% [2] - The Hang Seng China Central State-Owned Enterprises Dividend Index has also been performing well, hovering near historical highs [2] Group 2: Investment Strategies - Fund managers are highlighting the appeal of dividend stocks due to their defensive characteristics, especially as the market seeks stability [2][3] - The dividend yield of major dividend stocks has returned to over 4%, enhancing their long-term investment value [2] - The banking sector has experienced a significant correction, with a maximum drawdown of about 15%, and is now showing signs of stabilization [3] Group 3: Comparative Analysis - The Hang Seng China Central State-Owned Enterprises Dividend Index boasts a dividend yield of 6.02%, significantly higher than the CSI Dividend Index [4] - The price-to-book (PB) ratio for the Hang Seng index is 0.61, and the price-to-earnings (PE) ratio is 6.81, indicating strong dividend potential [4] - The banking and highway sectors are highlighted as prime examples of dividend stocks, with yields around 5% for A-shares and nearly 6% for Hong Kong stocks [4] Group 4: Institutional Investment - Insurance funds are expected to become a significant source of incremental capital in the stock market, with a focus on Hong Kong dividend stocks due to their low volatility and high dividend characteristics [5] - The regulatory environment is supportive of the dividend sector, which is expected to bolster its performance [5] - The banking sector, as a key component of Hong Kong dividends, is anticipated to see improvements in its fundamentals due to supportive monetary policies [5]
奥赛康(002755.SZ):创新药ASKC202在2025年ESMO年会公布临床研究数据
智通财经网· 2025-10-19 08:55
Core Viewpoint - The company announced that its subsidiary, Jiangsu Osaikang Pharmaceutical Co., Ltd., presented data on a novel cMET inhibitor, ASKC202, in combination with Lapatinib, at the European Society for Medical Oncology (ESMO) annual meeting in Berlin on October 18, 2025, focusing on patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who have failed epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and have MET amplification/overexpression [1] Group 1 - ASK202 in combination with Lapatinib demonstrated good tolerability and safety in patients with NSCLC who had previously failed EGFR-TKI treatment [1] - The treatment showed promising efficacy signals, including a high tumor response rate and prolonged duration of response [1] - A Phase III confirmatory clinical trial for ASK202 in combination with Lapatinib is currently underway [1]
本周申万医药生物指数下跌2.5%,关注2025 ESMO会议:医药行业周报(2025/10/13-2025/10/17)-20251019
Shenwan Hongyuan Securities· 2025-10-19 07:06
Investment Rating - The report indicates a current overall valuation of the pharmaceutical sector at 30.1 times earnings, ranking it 10th among 31 primary sectors in the market [5][8]. Core Insights - The pharmaceutical sector experienced a decline of 2.5% this week, underperforming compared to the Shanghai Composite Index, which fell by 1.5% [3][5]. - The report highlights significant corporate activities, including BMS's acquisition of Orbital Therapeutics for $1.5 billion, which includes a promising CAR-T therapy candidate and proprietary RNA platform technology [4][13]. - The report emphasizes the importance of the 2025 ESMO conference, where multiple Chinese pharmaceutical companies are expected to present clinical data, suggesting a focus on innovative drug sectors and companies with improving performance in medical devices and upstream sectors [4][19]. Market Performance Summary - The pharmaceutical sector's performance this week ranked 16th among 31 sub-industries, with various segments showing mixed results: - Raw materials (-2.3%) - Chemical preparations (-1.7%) - Traditional Chinese medicine (+0.4%) - Medical devices (-5.4%) [3][8]. - The report notes that the pharmaceutical sector's index has seen a decline of 2.5%, while the overall market (excluding financials and oil) dropped by 4.2% [3][5]. Key Events Recap - BMS's acquisition of Orbital Therapeutics is a notable event, as it aims to enhance its capabilities in CAR-T therapies [4][13]. - The approval of new indications for Pegasys by Teva Biopharma is expected to strengthen its market position in hepatitis treatment [4][15]. - Mindray Medical announced plans to issue H shares and list on the Hong Kong Stock Exchange to support its international strategy [4][15]. Clinical Data Highlights - The report includes a summary of clinical data presented at the 2025 ESMO conference, showcasing various drugs and their efficacy in treating different cancers, which may present investment opportunities [19][22].
银行利好竟是烟雾弹?机构直言:下周反弹是逃命机会,不是抄底信号!
Sou Hu Cai Jing· 2025-10-19 00:41
Market Overview - Over 4,700 stocks declined with a trading volume of 19.5 trillion, indicating a significant capital outflow from major players, leading to a "mini stock disaster" in the A-share market [1] - Mysterious funds entered the market towards the end of trading, purchasing 230 million in stocks like BYD and Tom Cat, suggesting a potential setup for a rebound next week [1] Policy and External Factors - The central bank's sudden call to "attract foreign investment" combined with signals of tariff easing led to a surge in A50 and Hong Kong futures [3] - This policy shift appears to be a strategy by major players to create a false rebound to attract retail investors [3] Market Sentiment and Historical Context - Historical data indicates that over 80% of rebounds during periods of declining sentiment are opportunities for major players to offload stocks [5] - The "fishing" tactic of major players is likely to repeat next week, with retail investors warned to be cautious of three traps: high-tech stocks' rebounds, sudden late-session stock surges, and low-volume rebounds [6] Defensive Assets and Sector Performance - Defensive assets have become a safe haven, with the precious metals sector rising against the trend, and bank stocks attracting 200 billion from insurance funds due to dividend yields exceeding 4% [8] - The previously hot AI sector, despite favorable news, lacks performance support from the application end [8] Technical Analysis and Trading Strategies - Key technical levels to watch include the 3,885-point support for the Shanghai Composite Index and the 3,000-point level for the ChiNext Index [8] - Analysts suggest that if the index fails to break through the 5-day moving average during a rebound, selling is the best option [9] Market Dynamics and Trading Behavior - Quantitative trading has intensified market volatility, with a trading volume of 1.1 trillion being a "hunting zone" for quant funds [11] - The behavior of foreign capital, which tends to sell before buying back, contrasts sharply with domestic major players [8] Investment Opportunities and Risks - The innovative drug sector is gaining traction due to the ESMO annual meeting, while low-valuation blue chips are seen as defensive choices [13] - The upcoming third-quarter reports are expected to reveal underperforming stocks, particularly those that have seen significant price increases [14] Global Market Interconnections - Increased interconnectivity in global markets is noted, with the impact of the Federal Reserve's balance sheet reduction affecting foreign capital flows [15][16] - The A-share market's rebound on October 15 coincided with a rise in Hong Kong stocks, although such correlations are often short-lived [17]
投资大家谈 | 景顺长城科技军团10月观点
点拾投资· 2025-10-18 11:00
Core Viewpoints - The article emphasizes the long-term optimism towards sectors such as semiconductors, innovative technology products, and innovative pharmaceuticals, while highlighting the structural opportunities arising from the "anti-involution" trend in the new energy sector [2][5]. Group 1: Semiconductor and AI Sector - The semiconductor and innovative technology sectors are expected to continue their growth trajectory, with a focus on structural opportunities amidst the "anti-involution" movement [2]. - The AI sector has seen significant breakthroughs, with expectations of increased market volatility following substantial short-term gains [3]. - Major companies like Oracle and Nvidia are making significant advancements in AI, indicating a robust growth outlook for the industry [4]. Group 2: Healthcare and Pharmaceuticals - The healthcare sector, particularly innovative pharmaceuticals, is anticipated to benefit from demographic trends such as aging populations and the internationalization of innovative drugs [5][10]. - There is a shift towards active stock selection in the pharmaceutical sector, with a focus on high-certainty stocks as the market enters a phase of differentiation [10][11]. Group 3: New Energy Sector - The new energy sector is facing challenges such as overcapacity, but there is growing confidence in investment opportunities, particularly in leading companies with cost advantages and innovative technologies [12]. - The government’s efforts to guide the industry towards "anti-involution" are seen as a catalyst for accelerating the clearing of inefficient capacities [12]. Group 4: Market Outlook and Investment Strategy - The overall market is expected to experience structural opportunities, with a focus on sectors like storage, resources, gaming, media, consumer electronics, and domestic computing power [6][8]. - The investment strategy includes a focus on high-quality companies with strong growth potential and reasonable valuations across various sectors, including electronics and automotive components [13].
海外路演需求增、跨境展业势头强 基金业全球化布局提速
Shang Hai Zheng Quan Bao· 2025-10-18 02:42
Group 1 - International investors are increasingly interested in Chinese assets, with a notable rise in inquiries and roadshow demands from regions such as North America, the Middle East, and Asia-Pacific [1][2] - The trend of foreign capital inflow into China's stock market is evident, with a reported net inflow of $4.6 billion in September, the highest monthly figure since November 2024 [2] - The number of mainland private equity firms holding Hong Kong's Type 9 license has increased to 92, indicating a growing trend of Chinese asset management firms expanding internationally [5] Group 2 - There is a significant shift in the types of foreign investors, with more market-oriented institutions like family offices and foundations showing interest in Chinese technology and industrial capabilities [3] - The asset management industry is focusing on building a global presence and enhancing core investment capabilities to meet diverse client needs and improve investment returns [4] - The Chinese asset management industry is actively participating in international promotional events to enhance its global influence and attract foreign capital [7] Group 3 - Despite the enthusiasm for international expansion, asset management firms face challenges such as macroeconomic uncertainties and regulatory differences in overseas markets [6] - Developing robust overseas investment research capabilities is crucial for successful international operations, emphasizing performance-driven strategies [6]